Cores, Biostatistics and Bioinformatics

In Cores, Biostatistics and Bioinformatics, our goal is to engineer solutions that can tackle disease-related problems in a way that is faster, cheaper and better, while training clinicians and researchers in the use of a cutting-edge systems approach to advance medicine. To better understand disease mechanisms and devise cost-effective strategies, we use advanced computing, electronics, informatics, imaging and mathematics to integrate biological, chemical, medical, behavioral and environmental data at multiple scales. Though our research, we aim to provide greater precision in diagnosis and therapy, earlier intervention, risk-based prevention, enhanced quality, coordination of care and optimization of the patient-clinician interface.

Our work has led to clinical trials for a new medical imaging device and several repositioned drugs, as well as an enterprise clinical data warehouse with analytic solutions for quality improvement, outcomes research and coordinated care. Through this work, we have delivered new approaches and methods in several areas of basic research and medical treatment including systems biology, informatics, cancer (specifically imaging and bioengineering), neurology, diabetes and orphan diseases.
Associate Director
Stephen Wong

Stephen Wong, PhD
John S. Dunn, Sr. Presidential Distinguished Chair in Biomedical Engineering,
Research Institute
Professor of Computer Science and Bioengineering in Oncology,
Institute for Academic Medicine
Houston Methodist
Weill Cornell Medical College

Drug Reprogramming
DNA Drug

Researcher uses DNA mapping to find new uses for old drugs. Read more in the Houston Chronicle>>


Cores, Biostatistics and Bioinformatics
Houston Methodist Research Institute
6670 Bertner Ave.
Houston, TX 77030

Stroma-Tumor Crosstalk

Transcriptome analysis of individual stromal cell populations identifies stroma-tumor crosstalk in mouse lung cancer model. Read more in Cell Reports>>